World’s biggest market for under-$100 million IPOs booms in India

By Satviki Sanjay and Ashutosh Joshi Small is beautiful in India’s market for initial public offerings after the disappointment of hyped mega-share sales.    From finance startup Paytm to the nation’s largest insurer, investors have lost money from those IPOs in the past two years. They’ve turned to companies offering up to… Continue reading World’s biggest market for under-$100 million IPOs booms in India

BSE market capitalisation at new high after benchmark indices gain

Benchmark indices snapped their two-day losing streak on Monday, led by gains in information technology (IT) stocks and index heavyweights such as Reliance Industries and HDFC Bank. Both the Sensex and the Nifty50 rose 0.6 per cent. Also on Monday, the market capitalisation of all the listed companies on the BSE logged a… Continue reading BSE market capitalisation at new high after benchmark indices gain

India’s smartphone market on the mend, Q2 CY23 shipments slip just 3%

Representative Image (Photo: Bloomberg) India’s smartphone handset shipments declined just 3 per cent year-on-year (YoY) in the second quarter (Q2) of calendar year 2023 (CY23), according to a report by Counterpoint.  The premium segment grew 112 per cent YoY during the quarter. Although Samsung pipped Apple in the premium smartphone segment (>Rs 30,000)… Continue reading India’s smartphone market on the mend, Q2 CY23 shipments slip just 3%

Market regulator Sebi looks to ease burden of compliance for India Inc

The Securities and Exchange Board of India (Sebi) has planned a series of steps to ease the regulatory and compliance burden for India Inc. The move comes amid concerns raised by some industry players that recent regulatory changes implemented by the capital markets watchdog are against the stated objective of the ease of doing… Continue reading Market regulator Sebi looks to ease burden of compliance for India Inc

Venus Remedies gets market authorisations for cancer drugs from 4 nations

Pharma major Venus Remedies on Monday said it has received market authorisations for its key cancer drugs from Philippines, Paraguay, Georgia and Moldova. With this, the company has secured 506 marketing approvals for its oncology products across 76 countries. While Venus Remedies has secured marketing approval for topotecan from Philippines, it has… Continue reading Venus Remedies gets market authorisations for cancer drugs from 4 nations

Domestic drug makers Sun Pharma, Alembic recall drugs in US market

Domestic drug makers Sun Pharma and Alembic are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). As per the US health regulator’s latest Enforcement Report, the Mumbai-based drug major is recalling 12,336 bottles of Buprenorphine Sublingual tablets, used for treating opioid use… Continue reading Domestic drug makers Sun Pharma, Alembic recall drugs in US market

Competition for market share intensifies among cement companies in Q1

Shree Cement to invest Rs 7,000 crore to add 12 million tonnes of capacity Star Cement soars 11%, nears 52-week high on heavy volumes Cement stocks riding high on hopes of higher demand, capex push ACC, Ambuja, Dalmia Cement: Analysts remain selective on cement stocks Ambuja-ACC and JK Lakshmi Cement lead race for Sanghi Cement… Continue reading Competition for market share intensifies among cement companies in Q1

Pelvic care is such a hot market, it’s hard to get the best help

The TikTok video begins with a young woman sitting in the passenger seat of her car, looking around unassumingly. Tense music builds to a crescendo, like in a horror movie. The video’s caption reads, “Doing Kegels all the time because I thought it was supposed to be good for me.” The woman looks over to… Continue reading Pelvic care is such a hot market, it’s hard to get the best help